Editas Medicine (EDIT) Goodwill & Intangibles (2020)
Editas Medicine (EDIT) reported Goodwill & Intangibles of $5.0 million for Q4 2020, little changed on a QoQ basis from $5.0 million in Q3 2020.
Editas Medicine (EDIT) has 1 years of Goodwill & Intangibles data on file, last reported at $5.0 million in Q4 2020.
- Quarterly Goodwill & Intangibles changed N/A year-over-year to $5.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $5.0 million (changed N/A YoY) and the FY2020 annual result came in at $5.0 million, changed N/A from the prior year.
- Goodwill & Intangibles steadied at $5.0 million in Q4 2020 per EDIT's latest filing, from $5.0 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $5.0 million in Q3 2020 and bottomed at $5.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 5.00 Mn |